Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh
· Delayed Price · Currency is BDT 12.20
-0.90 (-6.87%)
At close: Mar 8, 2026
DSE:IBP Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 | 2020 - 2016 |
| Net Income | -32.6 | -36.83 | -40.98 | 8.41 | 25.17 | 134.73 | Upgrade
|
| Depreciation & Amortization | 28.46 | 28.46 | 28.54 | 38.36 | 39.13 | 35.9 | Upgrade
|
| Loss (Gain) From Sale of Assets | 6.06 | 6.06 | - | -0.7 | - | 0.77 | Upgrade
|
| Other Operating Activities | -18.36 | -22.93 | 14.32 | 21.4 | -1.54 | 7.69 | Upgrade
|
| Change in Accounts Receivable | 6.02 | 6.02 | 21.39 | -4.72 | 26.82 | -19.67 | Upgrade
|
| Change in Inventory | 57.89 | 57.89 | 17.02 | 2.47 | 21.01 | -11.8 | Upgrade
|
| Change in Accounts Payable | 17.62 | 17.62 | 0.02 | -0.09 | 0.31 | 0.25 | Upgrade
|
| Change in Other Net Operating Assets | 2.16 | 2.16 | -6.55 | 7.82 | -23.61 | 3.17 | Upgrade
|
| Operating Cash Flow | 67.26 | 58.45 | 33.77 | 72.95 | 87.28 | 151.02 | Upgrade
|
| Operating Cash Flow Growth | 313.91% | 73.09% | -53.71% | -16.42% | -42.20% | -13.96% | Upgrade
|
| Capital Expenditures | -0.56 | -0.56 | -10.13 | -30.03 | -39.68 | -200.41 | Upgrade
|
| Sale (Purchase) of Real Estate | - | - | - | -13.44 | -14.5 | - | Upgrade
|
| Investing Cash Flow | -0.56 | -0.56 | -10.13 | -43.47 | -54.18 | -200.41 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 84.94 | Upgrade
|
| Total Debt Issued | -2.82 | - | - | - | - | 84.94 | Upgrade
|
| Short-Term Debt Repaid | - | -4.2 | -19.41 | -31.75 | -9.59 | - | Upgrade
|
| Total Debt Repaid | -5.1 | -4.2 | -19.41 | -31.75 | -9.59 | - | Upgrade
|
| Net Debt Issued (Repaid) | -7.92 | -4.2 | -19.41 | -31.75 | -9.59 | 84.94 | Upgrade
|
| Common Dividends Paid | -1.16 | -1.16 | -0.29 | -10.4 | -24.79 | -26.91 | Upgrade
|
| Other Financing Activities | -60.22 | -58.58 | -4.85 | -4.72 | -5.63 | - | Upgrade
|
| Financing Cash Flow | -69.3 | -63.94 | -24.55 | -46.87 | -40 | 58.03 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | - | 0 | 13.11 | Upgrade
|
| Net Cash Flow | -2.6 | -6.05 | -0.91 | -17.39 | -6.9 | 21.75 | Upgrade
|
| Free Cash Flow | 66.7 | 57.89 | 23.64 | 42.92 | 47.6 | -49.39 | Upgrade
|
| Free Cash Flow Growth | 524.30% | 144.90% | -44.92% | -9.84% | - | - | Upgrade
|
| Free Cash Flow Margin | 33.68% | 31.43% | 13.38% | 11.46% | 9.82% | -6.31% | Upgrade
|
| Free Cash Flow Per Share | 0.55 | 0.50 | 0.20 | 0.37 | 0.41 | -0.43 | Upgrade
|
| Cash Interest Paid | 4.39 | 1.87 | 4.85 | 4.72 | 5.63 | - | Upgrade
|
| Cash Income Tax Paid | - | - | 3.6 | - | 13.72 | 16.35 | Upgrade
|
| Levered Free Cash Flow | 103.51 | 97.36 | 29.92 | 15.65 | 75.07 | -74.57 | Upgrade
|
| Unlevered Free Cash Flow | 104.78 | 98.53 | 32.67 | 18.92 | 78.12 | -72.19 | Upgrade
|
| Change in Working Capital | 83.7 | 83.7 | 31.89 | 5.48 | 24.52 | -28.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.